These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 817252)

  • 1. C1 and human platelets. Decrease in chronic lymphocyte leukemia. Effect of lymphocytes.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Pathol Biol (Paris); 1975 Dec; 23 suppl():33-6. PubMed ID: 817252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1 and human platelets. III. Role of C1 subcomponents in platelet aggregation induced by aggregated IgG.
    Wautier JL; Souchon H; Solal LC; Peltier AP; Caen JP
    Immunology; 1976 Oct; 31(4):595-9. PubMed ID: 185144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of C1 subcomponents in platelet aggregation induced by aggregated IgG].
    Wautier JL; Souchon H; Peltier AP; Caen JP
    Ann Immunol (Paris); 1977; 128(1-2):81-2. PubMed ID: 848910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C1q (c1) receptor on human platelets: inhibition of collagen-induced platelet aggregation by C1q (C1) molecules.
    Suba EA; Csako G
    J Immunol; 1976 Jul; 117(1):304-9. PubMed ID: 1084367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C1 and human platelets. II. Detection by immunological methods and role.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Immunology; 1976 Apr; 30(4):459-65. PubMed ID: 818006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.
    Vollertsen RS; McDuffie FC; Bowie EJ
    Clin Exp Immunol; 1983 May; 52(2):423-9. PubMed ID: 6602680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of platelet aggregation by cationic protein from polymorphonuclear leukocytes.
    Wautier JL; Souchon H; Caen JP
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():23-6. PubMed ID: 796807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indirect platelet radioactive antiglobulin test in patients with lymphoproliferative disease.
    Garvey MB; Freedman J
    J Lab Clin Med; 1986 Feb; 107(2):123-8. PubMed ID: 3944493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for C1 on human platelets.
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Haemostasis; 1973-1974; 2(6):281-6. PubMed ID: 4213101
    [No Abstract]   [Full Text] [Related]  

  • 11. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First component of complement and thrombosis.
    Wautier JL; Ollier-Hartmann MP; Kadeva H; Cohen F; Hartmann L; Caen JP
    Thromb Haemost; 1981 Jun; 45(3):247-51. PubMed ID: 7281103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clq inhibition of the interaction of collagen with human platelets.
    Cazenave JP; Assimeh SN; Painter RH; Pachham MA; Mustard JF
    J Immunol; 1976 Jan; 116(1):162-3. PubMed ID: 1245737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repressed classical complement pathway activities and clinical correlations in chronic lymphocytic leukaemia.
    Miszlai Z; Czink E; Varga L; Pálóczi K; Szegedi G; Füst G; Hollán SR
    Acta Med Hung; 1986; 43(4):389-95. PubMed ID: 3601584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Letter: Platelet C1 in lymphoid syndromes].
    Wautier JL; Tobelem GM; Peltier AP; Caen JP
    Nouv Presse Med; 1976 Feb; 5(7):436. PubMed ID: 1257039
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunologic aggregation of human blood platelets and its inhibition in vitro].
    Malberg K; Elendt D; Elendt B
    Allerg Immunol (Leipz); 1986; 32(3):153-67. PubMed ID: 2947439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free platelet count and size distribution during C1q inhibition of collagen-induced platelet aggregation.
    Csako G; Suba EA
    Thromb Haemost; 1987 Aug; 58(2):682-5. PubMed ID: 3499680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of active C1 (C-1) on peripheral human lymphocytes.
    Kitamura H; Teshima H; Day NK
    Vox Sang; 1978; 35(4):197-206. PubMed ID: 99872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human blood platelets possess specific binding sites for C1q.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1987 Mar; 138(5):1537-41. PubMed ID: 3492557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of T lymphocytes from normal individuals and patients with B lymphocyte chronic lymphocytic leukaemia.
    Fernandez LA; MacSween JM; Langley GR
    Immunology; 1975 Feb; 28(2):231-41. PubMed ID: 1091543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.